Many hospitals won’t buy ease of use, because it’s too many steps to be useful; they’re waiting for Go to simplify by automation. Ease of use requires extra training time and expense compared to Go, and it saps sales reps of precious time that could otherwise be used to close more sales. Vitiligo indication is unlikely to rollout without it. CEO even said Go was necessary for international rollout, but maybe he’s just preparing for Go launch ultimately with the latest news. CEO did great job sugarcoating the Go delay. Made everyone happy with more debt, despite saying before that the company was well-capitalized. I’m happy with my debt. I’m happy with delay. Everything is OK.
Many hospitals won’t buy ease of use, because it’s too many...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.62 |
Change
-0.150(5.42%) |
Mkt cap ! $157.7M | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.66 | $2.58 | $1.612M | 614.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 13249 | $2.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.66 | 3448 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.62 |
Change
-0.150 ( 6.19 %) |
||||
| Open | High | Low | Volume | ||
| $2.61 | $2.65 | $2.61 | 10832 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| AVH (ASX) Chart |